Naloxone potentiates cardiopulmonary baroreflex sympathetic control in normal humans
- PMID: 1727685
- DOI: 10.1161/01.res.70.1.172
Naloxone potentiates cardiopulmonary baroreflex sympathetic control in normal humans
Abstract
Naloxone, an opioid antagonist, augments baroreflex mechanisms in animals; this occurrence suggests that endogenous opioids blunt baroreflex responses. Limited human studies suggest an inhibitory action of endogenous opioids on baroreflex-mediated vagal responses during arterial baroreceptor deactivation. To evaluate the potential effect of endogenous opioids on cardiopulmonary baroreflex mechanisms in humans, we measured arterial and central venous pressures, heart rate, and efferent muscle sympathetic nerve activity (MSNA, by peroneal microneurography) during unloading of cardiopulmonary baroreceptors with incremental lower body negative pressure (LBNP, from 0 to -15 mm Hg) and during the cold pressor test in 21 normal subjects (aged 24 +/- 1 [mean +/- SEM] years). In 14 subjects, we performed LBNP before and after naloxone (0.15 mg/kg i.v.) and placebo (n = 11) on separate days. In six of these 14 subjects and an additional seven subjects (n = 13), studies were also performed before and after administration of a lower dose of naloxone (0.075 mg/kg i.v.) on separate days. Neither dose of naloxone significantly altered control arterial or central venous pressures or heart rate. Control MSNA was reduced after the higher but not after the lower dose of naloxone. Comparable reductions in central venous pressure were produced by LBNP in all groups before and after naloxone or placebo, whereas LBNP did not alter arterial pressure. Cardiopulmonary baroreflex sympathetic sensitivity, which was derived as the slope of the linear regression relation between percent change in total MSNA (units) per absolute change in central venous pressure (mm Hg) during incremental LBNP, was significantly augmented after both the high dose (from 18.6 +/- 4.7%/mm Hg to 39.3 +/- 8.1%/mm Hg, p = 0.001) and low dose of naloxone, whereas placebo had no effect. MSNA responses to the cold pressor test were not altered by either dose of naloxone. Thus, naloxone selectively potentiates cardiopulmonary baroreflex regulation of sympathetic neural activity in normal humans. These findings suggest that endogenous opioids exert a tonic inhibitory effect on sympathetic responses to orthostatic stress in normal humans.
Similar articles
-
Nifedipine potentiates cardiopulmonary baroreflex control of sympathetic nerve activity in healthy humans. Direct evidence from microneurographic studies.Circulation. 1989 Aug;80(2):285-98. doi: 10.1161/01.cir.80.2.285. Circulation. 1989. PMID: 2752557 Clinical Trial.
-
Contrasting effects of digitalis and dobutamine on baroreflex sympathetic control in normal humans.Circulation. 1991 Sep;84(3):1118-29. doi: 10.1161/01.cir.84.3.1118. Circulation. 1991. PMID: 1884443 Clinical Trial.
-
Effects of lower-body negative pressure on sympathetic nerve responses to static exercise in humans. Microneurographic evidence against cardiac baroreflex modulation of the exercise pressor reflex.Circulation. 1988 Jul;78(1):49-59. doi: 10.1161/01.cir.78.1.49. Circulation. 1988. PMID: 3383410
-
Peripheral and central mechanisms of baroreflex resetting.Clin Exp Pharmacol Physiol Suppl. 1989;15:31-43. doi: 10.1111/j.1440-1681.1989.tb02994.x. Clin Exp Pharmacol Physiol Suppl. 1989. PMID: 2680188 Review.
-
Human investigations into the arterial and cardiopulmonary baroreflexes during exercise.Exp Physiol. 2012 Jan;97(1):39-50. doi: 10.1113/expphysiol.2011.057554. Epub 2011 Oct 14. Exp Physiol. 2012. PMID: 22002871 Free PMC article. Review.
Cited by
-
Cardiovascular effects of antiobesity drugs: are the new medicines all the same?Int J Obes Suppl. 2020 Jul;10(1):14-26. doi: 10.1038/s41367-020-0015-3. Epub 2020 Jul 20. Int J Obes Suppl. 2020. PMID: 32714509 Free PMC article. Review.
-
Low-dose fentanyl reduces pain perception, muscle sympathetic nerve activity responses, and blood pressure responses during the cold pressor test.Am J Physiol Regul Integr Comp Physiol. 2022 Jan 1;322(1):R64-R76. doi: 10.1152/ajpregu.00218.2021. Epub 2021 Dec 1. Am J Physiol Regul Integr Comp Physiol. 2022. PMID: 34851729 Free PMC article. Clinical Trial.
-
Naloxone-provoked vaso-vagal response to head-up tilt in men.Eur J Appl Physiol Occup Physiol. 1995;70(3):246-51. doi: 10.1007/BF00238571. Eur J Appl Physiol Occup Physiol. 1995. PMID: 7607200
-
Paroxysmal sympathetic hyperactivity risk modeling based on transients in time series describing the autonomic nervous system and cerebral hemodynamics.Acta Neurochir (Wien). 2025 May 30;167(1):158. doi: 10.1007/s00701-025-06566-9. Acta Neurochir (Wien). 2025. PMID: 40445402 Free PMC article.
-
Head-up tilt testing. The balance of evidence.Br Heart J. 1994 Sep;72(3):216-7. doi: 10.1136/hrt.72.3.216. Br Heart J. 1994. PMID: 7946767 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources